The 2018 midterm election results ushered in a divided government in Washington, DC. Healthcare was one of the key issues for many voters, which will make it a priority for both Chambers of Congress. Prescription drug prices, 340B program reform, addressing innovation in the regulatory process, removing regulatory barriers and strengthening the Affordable Care Act are among the topics facing Congress and the Administration.
Please join us for a discussion of how the healthcare and life science industries could be impacted by legislative and oversight agendas, the outlook for regulations and the possibility of cooperation between Capitol Hill and 1600 Pennsylvania Ave.
Wendy Goldstein – Partner, Cooley
Vince Sampson – Special Counsel, Cooley
For more information, please email Amanda Richardson or call +1 617 937 2460.